{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:54:00Z","timestamp":1778777640703,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Program for Public Wellbeing of China","award":["2012GS610101"],"award-info":[{"award-number":["2012GS610101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1055-x","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T13:03:59Z","timestamp":1554383039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction"],"prefix":"10.1186","volume":"19","author":[{"given":"Guodong","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiqun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-7967","authenticated-orcid":false,"given":"Tingzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"issue":"6","key":"1055_CR1","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137\u201361.","journal-title":"Circulation"},{"issue":"16","key":"1055_CR2","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, F. American College of Cardiology, G. American Heart Association Task Force on Practice. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147\u2013239.","journal-title":"J Am Coll Cardiol"},{"key":"1055_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2407-10-105","volume":"10","author":"V Askoxylakis","year":"2010","unstructured":"Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA, Debus J, Bischof M. Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer. 2010;10:105.","journal-title":"BMC Cancer"},{"key":"1055_CR4","first-page":"1","volume":"243","author":"KS Lewis","year":"2017","unstructured":"Lewis KS, Butler J, Bauersachs J, Sandner P. The three-decade long journey in heart failure drug development. Handb Exp Pharmacol. 2017;243:1\u201314.","journal-title":"Handb Exp Pharmacol"},{"issue":"15","key":"1055_CR5","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725\u201335.","journal-title":"Circulation"},{"issue":"6","key":"1055_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/105072502760143809","volume":"12","author":"WH Dillmann","year":"2002","unstructured":"Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid. 2002;12(6):447\u201352.","journal-title":"Thyroid"},{"issue":"7","key":"1055_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"1055_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jacc.2004.10.044","volume":"45","author":"A Ripoli","year":"2005","unstructured":"Ripoli A, Pingitore A, Favilli B, Bottoni A, Turchi S, Osman NF, De Marchi D, Lombardi M, L\u2019Abbate A, Iervasi G. Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol. 2005;45(3):439\u201345.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1055_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/105072502760143890","volume":"12","author":"B Biondi","year":"2002","unstructured":"Biondi B, Palmieri EA, Lombardi G, Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid. 2002;12(6):505\u201310.","journal-title":"Thyroid"},{"issue":"4","key":"1055_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526\u201334.","journal-title":"Arch Intern Med"},{"issue":"9821","key":"1055_CR11","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","volume":"379","author":"DS Cooper","year":"2012","unstructured":"Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142\u201354.","journal-title":"Lancet"},{"issue":"1","key":"1055_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"B Biondi","year":"2008","unstructured":"Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76\u2013131.","journal-title":"Endocr Rev"},{"issue":"2","key":"1055_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1210\/jc.2009-1845","volume":"95","author":"MI Surks","year":"2010","unstructured":"Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab. 2010;95(2):496\u2013502.","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"1055_CR14","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"M Jessup","year":"2009","unstructured":"Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF\/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977\u20132016.","journal-title":"Circulation"},{"key":"1055_CR15","doi-asserted-by":"crossref","unstructured":"Ro K, Yuen AD, Du L, Ro CC, Seger C, Yeh MW, Leung AM, Rhee CM. Impact of hypothyroidism and heart failure on hospitalization risk. Thyroid. 2018; 28(9):1094\u20131100.","DOI":"10.1089\/thy.2017.0362"},{"issue":"1","key":"1055_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cjca.2017.10.021","volume":"34","author":"Y Sato","year":"2018","unstructured":"Sato Y, Yoshihisa A, Kimishima Y, Kiko T, Watanabe S, Kanno Y, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y. Subclinical hypothyroidism is associated with adverse prognosis in heart failure patients. Can J Cardiol. 2018;34(1):80\u20137.","journal-title":"Can J Cardiol"},{"issue":"3","key":"1055_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ehf2.12084","volume":"3","author":"T Hayashi","year":"2016","unstructured":"Hayashi T, Hasegawa T, Kanzaki H, Funada A, Amaki M, Takahama H, Ohara T, Sugano Y, Yasuda S, Ogawa H, Anzai T. Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure. ESC Heart Fail. 2016;3(3):168\u201376.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"1055_CR18","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1210\/jc.2014-4159","volume":"100","author":"W Wang","year":"2015","unstructured":"Wang W, Guan H, Gerdes AM, Iervasi G, Yang Y, Tang YD. Thyroid status, cardiac function, and mortality in patients with idiopathic dilated cardiomyopathy. J Clin Endocrinol Metab. 2015;100(8):3210\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1055_CR19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.amjcard.2015.01.559","volume":"115","author":"AK Sharma","year":"2015","unstructured":"Sharma AK, Vegh E, Orencole M, Miller A, Blendea D, Moore S, Lewis GD, Singh JP, Parks KA, Heist EK. Association of hypothyroidism with adverse events in patients with heart failure receiving cardiac resynchronization therapy. Am J Cardiol. 2015;115(9):1249\u201353.","journal-title":"Am J Cardiol"},{"issue":"7","key":"1055_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cardfail.2014.05.002","volume":"20","author":"X Li","year":"2014","unstructured":"Li X, Yang X, Wang Y, Ding L, Wang J, Hua W. The prevalence and prognostic effects of subclinical thyroid dysfunction in dilated cardiomyopathy patients: a single-center cohort study. J Card Fail. 2014;20(7):506\u201312.","journal-title":"J Card Fail"},{"issue":"1","key":"1055_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jchf.2013.07.008","volume":"2","author":"AC Perez","year":"2014","unstructured":"Perez AC, Jhund PS, Stott DJ, Gullestad L, Cleland JG, van Veldhuisen DJ, Wikstrand J, Kjekshus J, McMurray JJ. Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure). JACC Heart Fail. 2014;2(1):35\u201340.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"1055_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ejhf.42","volume":"16","author":"S Chen","year":"2014","unstructured":"Chen S, Shauer A, Zwas DR, Lotan C, Keren A, Gotsman I. The effect of thyroid function on clinical outcome in patients with heart failure. Eur J Heart Fail. 2014;16(2):217\u201326.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"1055_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ejhf.30","volume":"16","author":"VM Deursen van","year":"2014","unstructured":"van Deursen VM, Urso R, Laroche C, Damman K, Dahlstrom U, Tavazzi L, Maggioni AP, Voors AA. Co-morbidities in patients with heart failure: an analysis of the European heart failure pilot survey. Eur J Heart Fail. 2014;16(1):103\u201311.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"1055_CR24","first-page":"409","volume":"77","author":"T Azemi","year":"2013","unstructured":"Azemi T, Bhavnani S, Kazi F, Coleman CI, Guertin D, Kluger J, Clyne CA. Prognostic impact of thyroid stimulating hormone levels in patients with cardiomyopathy. Conn Med. 2013;77(7):409\u201315.","journal-title":"Conn Med"},{"issue":"1","key":"1055_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jchf.2012.10.004","volume":"1","author":"JE Mitchell","year":"2013","unstructured":"Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Johnson GW, Poole JE, Lee KL, Bardy GH. Thyroid function in heart failure and impact on mortality. JACC Heart Fail. 2013;1(1):48\u201355.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"1055_CR26","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1210\/jc.2013-1039","volume":"98","author":"CM Rhee","year":"2013","unstructured":"Rhee CM, Curhan GC, Alexander EK, Bhan I, Brunelli SM. Subclinical hypothyroidism and survival: the effects of heart failure and race. J Clin Endocrinol Metab. 2013;98(6):2326\u201336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1055_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijcard.2012.09.064","volume":"168","author":"A Frey","year":"2013","unstructured":"Frey A, Kroiss M, Berliner D, Seifert M, Allolio B, Guder G, Ertl G, Angermann CE, Stork S, Fassnacht M. Prognostic impact of subclinical thyroid dysfunction in heart failure. Int J Cardiol. 2013;168(1):300\u20135.","journal-title":"Int J Cardiol"},{"issue":"26","key":"1055_CR28","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.2174\/138161208786264142","volume":"14","author":"M Iacoviello","year":"2008","unstructured":"Iacoviello M, Guida P, Guastamacchia E, Triggiani V, Forleo C, Catanzaro R, Cicala M, Basile M, Sorrentino S, Favale S. Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. Curr Pharm Des. 2008;14(26):2686\u201392.","journal-title":"Curr Pharm Des"},{"issue":"30","key":"1055_CR29","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1097\/MD.0000000000001159","volume":"94","author":"N Ning","year":"2015","unstructured":"Ning N, Gao D, Triggiani V, Iacoviello M, Mitchell JE, Ma R, Zhang Y, Kou H. Prognostic role of hypothyroidism in heart failure: a meta-analysis. Medicine (Baltimore). 2015;94(30):e1159.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1055_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1871530311313010005","volume":"13","author":"V Triggiani","year":"2013","unstructured":"Triggiani V, Iacoviello M. Thyroid disorders in chronic heart failure: from prognostic set-up to therapeutic management. Endocr Metab Immune Disord Drug Targets. 2013;13(1):22\u201337.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"1055_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/187153012799278947","volume":"12","author":"V Triggiani","year":"2012","unstructured":"Triggiani V, Iacoviello M, Monzani F, Puzzovivo A, Guida P, Forleo C, Ciccone MM, Catanzaro R, Tafaro E, Licchelli B, Giagulli VA, Guastamacchia E, Favale S. Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone. Endocr Metab Immune Disord Drug Targets. 2012;12(1):86\u201394.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"11","key":"1055_CR32","first-page":"CR481","volume":"12","author":"C Marcisz","year":"2006","unstructured":"Marcisz C, Jonderko G, Wroblewski T, Kurzawska G, Mazur F. Left ventricular mass in patients with hyperthyroidism. Med Sci Monit. 2006;12(11):CR481\u20136.","journal-title":"Med Sci Monit"},{"issue":"2","key":"1055_CR33","first-page":"131","volume":"105","author":"C Marcisz","year":"2001","unstructured":"Marcisz C, Kucharz EJ, Jonderko G, Wojewodka J. The systolic function of the left ventricle of the heart in patients with hyperthyroidism during therapy. Pol Arch Med Wewn. 2001;105(2):131\u20138.","journal-title":"Pol Arch Med Wewn"},{"issue":"1\u20132","key":"1055_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07435800701670047","volume":"32","author":"B Ozmen","year":"2007","unstructured":"Ozmen B, Ozmen D, Parildar Z, Mutaf I, Bayindir O. Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism. Endocr Res. 2007;32(1\u20132):1\u20138.","journal-title":"Endocr Res"},{"issue":"3","key":"1055_CR35","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1210\/jcem.86.3.7291","volume":"86","author":"F Monzani","year":"2001","unstructured":"Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C, Ferrannini E. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab. 2001;86(3):1110\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1055_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1067\/mje.2000.106397","volume":"13","author":"V Bello Di","year":"2000","unstructured":"Di Bello V, Monzani F, Giorgi D, Bertini A, Caraccio N, Valenti G, Talini E, Paterni M, Ferrannini E, Giusti C. Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J Am Soc Echocardiogr. 2000;13(9):832\u201340.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"1055_CR37","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1210\/jcem.84.6.5733","volume":"84","author":"B Biondi","year":"1999","unstructured":"Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bone F, Lombardi G, Sacca L. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1999;84(6):2064\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1055_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, E.S.C.S.D. Group. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67\u2013119.","journal-title":"Eur Heart J"},{"issue":"3","key":"1055_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1378\/chest.07-0366","volume":"132","author":"JH Li","year":"2007","unstructured":"Li JH, Safford RE, Aduen JF, Heckman MG, Crook JE, Burger CD. Pulmonary hypertension and thyroid disease. Chest. 2007;132(3):793\u20137.","journal-title":"Chest"},{"issue":"2","key":"1055_CR40","doi-asserted-by":"publisher","first-page":"e29361","DOI":"10.5812\/cardiovascmed.29361","volume":"5","author":"F Vakilian","year":"2016","unstructured":"Vakilian F, Attaran D, Shegofte M, Lari S, Ghare S. Assessment of thyroid function in idiopathic pulmonary hypertension. Res Cardiovasc Med. 2016;5(2):e29361.","journal-title":"Res Cardiovasc Med"},{"issue":"1","key":"1055_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","volume":"37","author":"S Ghio","year":"2001","unstructured":"Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37(1):183\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1055_CR42","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/ehjci\/jeu147","volume":"15","author":"O Fabregat-Andres","year":"2014","unstructured":"Fabregat-Andres O, Estornell-Erill J, Ridocci-Soriano F, Garcia-Gonzalez P, Bochard-Villanueva B, Cubillos-Arango A, Espriella-Juan Rde L, Facila L, Morell S, Cortijo J. Prognostic value of pulmonary vascular resistance estimated by cardiac magnetic resonance in patients with chronic heart failure. Eur Heart J Cardiovasc Imaging. 2014;15(12):1391\u20139.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"1055_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/s-0029-1212126","volume":"107","author":"LH Duntas","year":"1999","unstructured":"Duntas LH, Papanastasiou L, Mantzou E, Koutras DA. Incidence of sideropenia and effects of iron repletion treatment in women with subclinical hypothyroidism. Exp Clin Endocrinol Diabetes. 1999;107(6):356\u201360.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"177","key":"1055_CR44","first-page":"101","volume":"45","author":"L Horton","year":"1976","unstructured":"Horton L, Coburn RJ, England JM, Himsworth RL. The haematology of hypothyroidism. Q J Med. 1976;45(177):101\u201323.","journal-title":"Q J Med"},{"issue":"4","key":"1055_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/10507250252949405","volume":"12","author":"LH Duntas","year":"2002","unstructured":"Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287\u201393.","journal-title":"Thyroid"},{"issue":"2","key":"1055_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0021-9150(02)00372-6","volume":"166","author":"M Christ-Crain","year":"2003","unstructured":"Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Muller B. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166(2):379\u201386.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1055_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132(4):270\u20138.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1055_CR48","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","volume":"304","author":"N Rodondi","year":"2010","unstructured":"Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J, Thyroid Studies C. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365\u201374.","journal-title":"JAMA"},{"key":"1055_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1210\/rp.59.1.31","volume":"59","author":"S Fazio","year":"2004","unstructured":"Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004;59:31\u201350.","journal-title":"Recent Prog Horm Res"},{"issue":"19","key":"1055_CR50","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","volume":"331","author":"CT Sawin","year":"1994","unstructured":"Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D\u2019Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331(19):1249\u201352.","journal-title":"N Engl J Med"},{"issue":"3","key":"1055_CR51","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1210\/jcem.87.3.8217","volume":"87","author":"F Osman","year":"2002","unstructured":"Osman F, Gammage MD, Sheppard MC, Franklyn JA. Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace? J Clin Endocrinol Metab. 2002;87(3):963\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1055_CR52","first-page":"4701","volume":"85","author":"B Biondi","year":"2000","unstructured":"Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G, Perticone F. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab. 2000;85(12):4701\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1055_CR53","doi-asserted-by":"publisher","first-page":"904","DOI":"10.7326\/0003-4819-137-11-200212030-00011","volume":"137","author":"B Biondi","year":"2002","unstructured":"Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002;137(11):904\u201314.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1055_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1210\/jcem.85.1.6298","volume":"85","author":"G Mercuro","year":"2000","unstructured":"Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F, Mariotti S. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab. 2000;85(1):159\u201364.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1055-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T09:46:42Z","timestamp":1585907202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1055-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1055-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"83"}}